Search Results - "Khamaisie, H"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    794: Crizotinib is an allosteric ABL-inhibitor targeting both native BCR/ABL and BCR/ABL-T315I in vitro and in vivo models of PH+ leukemia

    794: Crizotinib is an allosteric ABL-inhibitor targeting both native BCR/ABL and BCR/ABL-T315I in vitro and in vivo models of PH+ leukemia by Mahajna, J, Khamaisie, H, Ruimi, N, Agbarya, A, Eshel, E, Dally, N, Ottmann, O, Biondi, R, Mian, A.A, Ruthardt, M

    Published in European journal of cancer (1990) (01-07-2014)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Oleic Acid Is the Active Component in the Mushroom Daedalea gibbosa Inhibiting Bcr-Abl Kinase Autophosphorylation Activity

    Oleic Acid Is the Active Component in the Mushroom Daedalea gibbosa Inhibiting Bcr-Abl Kinase Autophosphorylation Activity by KHAMAISIE, Hazem, SUSSAN, Sherbel, TAL, Michael, NAJAJREH, Yousef, RUTHARDT, Martin, MAHAJNA, Jamal

    Published in Anticancer research (2011)
    “…The hallmark of chronic myeloid leukemia (CML) is the abnormal activity of p210(Bcr-Abl) kinase. Selective kinase inhibitors such as imatinib or nilotinib have…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: